DSpace@İnönü

Impact of adjuvant treatment modalities on survival outcomes in

Basit öğe kaydını göster

dc.contributor.author Turan, N
dc.contributor.author Benekli, M
dc.contributor.author Unal, OU
dc.contributor.author Unek, IT
dc.contributor.author Tastekin, D
dc.contributor.author Dane, F
dc.contributor.author Algin, E
dc.contributor.author Ulger, S
dc.contributor.author Eren, T
dc.contributor.author Topcu, TO
dc.contributor.author Turkmen, E
dc.contributor.author Babacan, NA
dc.contributor.author Tufan, G
dc.contributor.author Urakci, Z
dc.contributor.author Ustaalioglu, BO
dc.contributor.author Uysal, OS
dc.contributor.author Ercelep, OB
dc.contributor.author Taskoylu, BY
dc.contributor.author Aksoy, A
dc.contributor.author Canhoroz, M
dc.contributor.author Demirci, U
dc.contributor.author Dogan, E
dc.contributor.author Berk, V
dc.contributor.author Balakan, O
dc.contributor.author Ekinci, AS
dc.contributor.author Uysal, M
dc.contributor.author Petekkaya, I
dc.contributor.author Ozturk, SC
dc.contributor.author Tonyali, O
dc.contributor.author Cetin, B
dc.contributor.author Aldemir, MN
dc.contributor.author Helvaci, K
dc.contributor.author Ozdemir, N
dc.contributor.author Oztop, I
dc.contributor.author Coskun, U
dc.contributor.author Uner, A
dc.contributor.author Ozet, A
dc.contributor.author Buyukberber, S
dc.date.accessioned 2022-10-13T11:46:44Z
dc.date.available 2022-10-13T11:46:44Z
dc.date.issued 2015
dc.identifier.uri http://hdl.handle.net/11616/79623
dc.description.abstract Background: We examined the impact of adjuvant modalities on resected pancreatic and periampullary adenocarcinoma (PAC).
dc.description.abstract Methods: A total of 563 patients who were curatively resected for PAC were retrospectively analyzed between 2003 and 2013.
dc.description.abstract Results: Of 563 patients, 472 received adjuvant chemotherapy (CT) alone, chemoradiotherapy (CRT) alone, and chemoradiotherapy plus chemotherapy (CRT-CT) were analyzed. Of the 472 patients, 231 were given CRT-CT, 26 were given CRT, and 215 were given CT. The median recurrence-free survival (RFS) and overall survival (OS) were 12 and 19 months, respectively. When CT and CRT-CT groups were compared, there was no significant difference with respect to both RFS and OS, and also there was no difference in RFS and OS among CRT-CT, CT and CRT groups. To further investigate the impact of radiation on subgroups, patients were stratified according to lymph node status and resection margins. In node-positive patients, both RFS and OS were significantly longer in CRT-CT than CT. In contrast, there was no significant difference between groups when patients with node-negative disease or patients with or without positive surgical margins were considered.
dc.description.abstract Conclusions: Addition of radiation to CT has a survival benefit in patients with node-positive disease following pancreatic resection.
dc.description.abstract C1 [Turan, Nedim; Babacan, Nalan Akgul] Cumhuriyet Univ, Fac Med, Dept Med Oncol, TR-58140 Sivas, Turkey.
dc.description.abstract [Benekli, Mustafa; Algin, Efnan; Cetin, Bulent; Coskun, Ugur; Uner, Aytug; Ozet, Ahmet; Buyukberber, Suleyman] Gazi Univ, Fac Med, Dept Med Oncol, TR-06560 Ankara, Turkey.
dc.description.abstract [Unal, Olcun Umit; Unek, Ilkay Tugba; Oztop, Ilhan] Dokuz Eylul Univ, Fac Med, Dept Med Oncol, TR-35340 Izmir, Turkey.
dc.description.abstract [Tastekin, Didem] Necmettin Erbakan Univ, Fac Med, Dept Med Oncol, TR-42080 Konya, Turkey.
dc.description.abstract [Dane, Faysal] Marmara Univ, Fac Med, Dept Med Oncol, TR-34000 Istanbul, Turkey.
dc.description.abstract [Ulger, Sukran] Gazi Univ, Fac Med, Dept Radiat Oncol, TR-06560 Ankara, Turkey.
dc.description.abstract [Eren, Tulay; Ozdemir, Nuriye] Numune Educ & Res Hosp, Dept Med Oncol, TR-06100 Ankara, Turkey.
dc.description.abstract [Topcu, Turkan Ozturk] Karadeniz Tech Univ, Fac Med, Dept Med Oncol, TR-61000 Trabzon, Turkey.
dc.description.abstract [Turkmen, Esma] Trakya Univ, Fac Med, Dept Med Oncol, TR-22020 Edirne, Turkey.
dc.description.abstract [Tufan, Gulnihal] Rize Educ & Res Hosp, Dept Med Oncol, TR-53200 Rize, Turkey.
dc.description.abstract [Urakci, Zuhat] Dicle Univ, Fac Med, Dept Med Oncol, TR-21280 Diyarbakir, Turkey.
dc.description.abstract [Ustaalioglu, Basak Oven; Ercelep, Ozlem Balvan] Dr Lutfi Kirdar Kartal Educ & Res Hosp, Dept Med Oncol, TR-34668 Istanbul, Turkey.
dc.description.abstract [Uysal, Ozlem Sonmez] Sakarya Educ & Res Hosp, Dept Med Oncol, TR-54050 Sakarya, Turkey.
dc.description.abstract [Taskoylu, Burcu Yapar] Pamukkale Univ, Fac Med, Dept Med Oncol, TR-20070 Denizli, Turkey.
dc.description.abstract [Aksoy, Asude] Inonu Univ, Fac Med, Dept Med Oncol, TR-44315 Malatya, Turkey.
dc.description.abstract [Canhoroz, Mustafa] Firat Univ, Fac Med, Dept Med Oncol, TR-23200 Elazig, Turkey.
dc.description.abstract [Demirci, Umut; Helvaci, Kaan] Dr Abdurrahman Yurtaslan Educ & Res Hosp, Dept Med Oncol, TR-06200 Ankara, Turkey.
dc.description.abstract [Dogan, Erkan] Yuzuncu Yil Univ, Fac Med, Dept Med Oncol, TR-65080 Van, Turkey.
dc.description.abstract [Berk, Veli] Erciyes Univ, Fac Med, Dept Med Oncol, TR-38000 Kayseri, Turkey.
dc.description.abstract [Balakan, Ozan] SutcuImam Univ, Fac Med, Dept Med Oncol, TR-46100 Kahramanmaras, Turkey.
dc.description.abstract [Ekinci, Ahmet Siyar] Diyarbakir Educ & Res Hosp, Dept Med Oncol, TR-21010 Diyarbakir, Turkey.
dc.description.abstract [Uysal, Mukremin] Afyon Kocatepe Univ, Fac Med, Dept Med Oncol, TR-03200 Afyon, Turkey.
dc.description.abstract [Petekkaya, Ibrahim] Dr Ersin Arslan State Hosp, Dept Med Oncol, TR-27010 Gaziantep, Turkey.
dc.description.abstract [Ozturk, Selcuk Cemil] Adiyaman Univ, Educ & Res Hosp, Dept Med Oncol, TR-02040 Adiyaman, Turkey.
dc.description.abstract [Tonyali, Onder] Mustafa Kemal Univ, Fac Med, Dept Med Oncol, TR-31070 Antakya, Turkey.
dc.description.abstract [Aldemir, Mehmet Naci] Ataturk Univ, Fac Med, Dept Med Oncol, TR-25240 Erzurum, Turkey.
dc.source CHINESE JOURNAL OF CANCER RESEARCH
dc.title Impact of adjuvant treatment modalities on survival outcomes in
dc.title curatively resected pancreatic and periampullary adenocarcinoma


Bu öğenin dosyaları:

Dosyalar Boyut Biçim Göster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster